caffeine has been researched along with alprostadil in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Hasegawa, T; Kumagai, S | 1 |
| Auclair, MC; Lechat, P; Vernimmen, C | 1 |
| Dziubinski, J; Mackenzie, TB; Popkin, MK; Sheppard, JR | 1 |
| Biaggioni, I; Kurunwune, B; Paul, S | 1 |
| Belzowzki, A; Bergren, D; Brugler, A; Hillman, BG; Hillman, KC; Hillman, SR; Kuss, B; Ngo, BT; Pisarri, T; Rendell, MS; Thompson, SL; Turner, SA | 1 |
9 other study(ies) available for caffeine and alprostadil
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A G-protein of sarcoplasmic reticulum of skeletal muscle is activated by caffeine or inositol trisphosphate.
Topics: Alprostadil; Animals; Caffeine; Calcium; GTP Phosphohydrolases; GTP-Binding Proteins; Indomethacin; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Kinetics; Muscles; Phosphoric Monoester Hydrolases; Ranidae; Sarcoplasmic Reticulum; Sugar Phosphates | 1989 |
Influence of prostacyclin and two metabolites on the contractility of cultured rat heart cells.
Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Animals; Caffeine; Cells, Cultured; Epoprostenol; Myocardial Contraction; Myocardium; Rats; Vasodilator Agents | 1988 |
Effects of caffeine withdrawal on isoproterenol-stimulated cyclic adenosine monophosphate.
Topics: Adrenal Medulla; Adult; Alprostadil; Caffeine; Cyclic AMP; Drug Tolerance; Humans; In Vitro Techniques; Isoproterenol; Lymphocytes; Male; Prostaglandins E; Receptors, Adrenergic; Substance Withdrawal Syndrome | 1981 |
Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adolescent; Adult; Alprostadil; Blood Platelets; Caffeine; Epoprostenol; Humans; Male; Models, Biological; Purinergic P1 Receptor Antagonists; Receptors, Epoprostenol; Receptors, Prostaglandin; Receptors, Purinergic P1; Sensitivity and Specificity; Substance Withdrawal Syndrome; Up-Regulation | 1993 |
The effect of vasoactive agents on post-pressure hyperemia.
Topics: Adenosine; Alprostadil; Animals; Area Under Curve; Arterial Pressure; Buffers; Caffeine; Dinoprostone; Dopamine; Epinephrine; Humans; Hyperemia; Microdialysis; NG-Nitroarginine Methyl Ester; Phosphates; Rats; Rats, Wistar; Regional Blood Flow; Skin; Time Factors; Vasoconstrictor Agents | 2012 |